Related Experiment Videos

Fibronectin in pemphigus

Dermatologica
|January 1, 1987
PubMed

Insights

Fibronectin may protect against pemphigus by reducing antibody penetration in the skin. Lower fibronectin levels correlate with active pemphigus disease, suggesting a potential therapeutic role.

Area of Science:

  • Dermatology
  • Immunology
  • Biochemistry

Background:

  • Pemphigus is an autoimmune blistering disease affecting the skin.
  • The role of fibronectin in pemphigus pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the potential protective role of fibronectin in pemphigus.
  • To examine fibronectin levels in pemphigus patients and its correlation with disease activity.

Main Methods:

  • Skin organ culture model to assess fibronectin's effect on acantholysis.
  • Chromatography and precipitation assays to evaluate fibronectin-antibody interaction.
  • Measurement of plasma and blister fluid fibronectin concentrations in pemphigus patients.

Main Results:

  • High fibronectin concentrations inhibited pemphigus plasma-induced acantholysis and antibody binding in vitro.
  • No direct interaction was found between fibronectin and pemphigus antibodies.
  • Pemphigus patients with active disease showed low to subnormal plasma fibronectin levels.
  • Fibronectin levels tended to decrease with disease remission during treatment.

Conclusions:

  • Fibronectin may exert a protective effect in pemphigus, potentially by limiting antibody access to the dermal-epidermal junction.
  • Reduced fibronectin levels in active pemphigus suggest its involvement in disease progression.

Related Concept Videos